Miriam Bujny

Company: Sapreme Technologies

Job title: Chief Development Officer (CDO)

Seminars:

Overcoming Endosomal Entrapment in Oligonucleotide Delivery 1:00 pm

Explore the challenges of endosomal entrapment in delivering oligonucleotide payloads and the critical role of endosomal escape enhancers in maximising intracellular delivery and therapeutic efficacy Discuss the evolution of antibody-oligonucleotide conjugates as promising modalities for RNA therapies, and the imperative of enhancing endosomal escape for effective delivery beyond hepatic targets Showcasing a diverse portfolio of…Read more

day: Conference Day 1

Securing Buy-In from Pharma Partnerships and Investors 2:30 pm

How can we effectively present proof of concept, pharmacokinetic (PK), and toxicity data to persuade conservative investors to fund next-generation conjugate projects in Europe? Which specific metrics and evidence, such as efficacy data, market potential, or comparative advantages over existing therapies, are most persuasive for investors when considering funding for next-generation conjugates? In what ways…Read more

day: Conference Day 2